CG Oncology, Inc. · NASDAQ:CGON
CG Oncology, Inc. financial statements
CG Oncology, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 4.04M | 1.14M | 204.0K |
| Research and development | 116.6M | 82.1M | 45.8M |
| Operating income | -190.8M | -114.7M | -55.4M |
| Depreciation and amortization | 1.45M | 32.0K | 17.0K |
| EBITDA | -189.3M | -114.6M | -55.4M |
| Income tax | -270.0K | 1.00K | 1.00K |
| Net income | -161.0M | -88.0M | -48.6M |
| Earnings per share, basic | -2.08 | -1.41 | -15.65 |
| Earnings per share, diluted | -2.08 | -1.41 | -15.65 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash and equivalents | 32.5M | 257.1M | 8.27M |
| Short-term investments | 709.7M | 484.9M | 179.4M |
| Receivables | 688.0K | 0 | |
| Inventory | 1.56M | 0 | |
| Current assets | 759.5M | 754.2M | 194.1M |
| Property, plant and equipment | 15.6M | 272.0K | 69.0K |
| Goodwill | 10.3M | 0 | |
| Total assets | 791.6M | 754.8M | 199.3M |
| Accounts payable | 5.71M | 6.52M | 3.24M |
| Current liabilities | 30.8M | 21.4M | 14.3M |
| Long-term debt | 3.00M | 0 | |
| Total debt | 3.00M | 0 | |
| Total liabilities | 39.0M | 21.4M | 14.5M |
| Shareholders' equity | 752.6M | 733.4M | -123.1M |
| Shares outstanding | 80.7M | 76.2M | 5.22M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Cash from operations | -132.3M | -78.7M | -45.7M |
| Capital spending | -134.0K | -234.0K | |
| Free cash flow | -132.5M | -78.9M | |
| Cash from investing | -245.8M | -300.8M | -121.2M |
| Cash from financing | 153.6M | 628.3M | 87.0M |
| Change in cash | -224.6M | 248.8M | -79.9M |